[123I] IBVM and SPECT imaging

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	2

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00556764 (ClinicalTrials.gov)	July 2007	8/11/2007	Development of Cognitive Assessment Tools in Parkinson Disease	Development of Cognitive Assessment Tools in Parkinson Disease	Parkinson Disease	Drug: [123I] IBVM and SPECT imaging;Drug: Subjects will undergo the 123-I IBVM imaging visit	Institute for Neurodegenerative Disorders	Department of Defense;University of Oklahoma	Completed	30 Years	N/A	Both	75	Phase 0	United States
2	NCT00480701 (ClinicalTrials.gov)	February 2007	30/5/2007	Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imagingof Healthy Subjects andPatients With ...	Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECTas a Marker of Acetylcholine Transporter Dens ...	Alzheimer Disease;Parkinson Disease	Drug: [123I]-IBVM	Institute for Neurodegenerative Disorders	NULL	Completed	50 Years	N/A	Both	26	Phase 2	United States

First Previous1Next Last